InvestorsHub Logo
Followers 58
Posts 10055
Boards Moderated 1
Alias Born 09/21/2016

Re: Talon38 post# 365671

Saturday, 07/09/2022 8:52:09 AM

Saturday, July 09, 2022 8:52:09 AM

Post# of 458818
Talon 38 , thx , appreciate your comments and do agree , we are soon going to be in a different place and "on top ". Doing a job of conducting trials in the most effective manner requires knowledge and skills in execution, that must continue and will be an ongoing responsibility .

BUT, I am expecting that at some point the emphasis switches from planning and execution to results analysis and ongoing clinical-learning & system support. We will see trial results. Results have to be assessed and analyzed. There will (no doubt be good and (NOT) good days going forward . BUT, IMO this kind of next step plays well into the AVXL skill set. Only a matter of time till DR.M. and staff get WW recognition as the next true value level of our MOA begins to be analyzed and deeply understood. We will move through, " what we know we do not know" , into the next space.(Dr.P. Senge)

I hope and pray that the positives in Quality of Life (QOL) for the kids and adult patients we continue to support develops quickly and that they see their new lives immediately. We each want and deserve the payback-feedback after years of work.

Very much appreciate your personal courage and service. CAVU, good day sir.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News